Literature DB >> 24388397

Multiple EWSR1-WT1 and WT1-EWSR1 copies in two cases of desmoplastic round cell tumor.

Roberta La Starza1, Gianluca Barba1, Valeria Nofrini1, Tiziana Pierini1, Valentina Pierini1, Luca Marcomigni2, Katia Perruccio2, Caterina Matteucci1, Clelia Tiziana Storlazzi3, Giulia Daniele3, Barbara Crescenzi1, Michele Giansanti4, Paolo Giovenali5, Paola Dal Cin6, Cristina Mecucci7.   

Abstract

To provide new insights into the genomic profile of desmoplastic round cell tumors (DSRCT), we applied fluorescence in situ hybridization (FISH) and metaphase comparative genomic hybridization (M-CGH) to two newly diagnosed cases. FISH detected multiple subclones bearing one to three copies of der(11)t(11;22)(p13;q12) and/or der(22)t(11;22)(p13;q12) in both patients. This peculiar genomic imbalance might result from derivative chromosome duplication due to non-disjunction and/or mitotic recombination between normal and derivative chromosomes 11 and 22. Concomitant loss of normal chromosomes (i.e., 11 in patient 1 and 22 in patient 2) caused loss of the WT1 or EWSR1 wild-type allele. M-CGH identified other genomic imbalances: gain at chromosome 3 in both cases and chromosome 5 polysomy in patient 1. Common genomic events (i.e., trisomy 3 and extra EWSR1-WT1 and WT1-EWSR1 copies) probably contributed to disease pathogenesis and/or evolution of DSRCT. Our study demonstrated that an integrated molecular cytogenetic approach identified EWSR1-WT1 cooperating molecular events and genetic markers for prognosis. Thus, FISH and M-CGH might well be applied in a large series of patients to elucidate the genomic background of DSRCT.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  EWSR1-WT1; FISH; M-CGH

Mesh:

Substances:

Year:  2013        PMID: 24388397     DOI: 10.1016/j.cancergen.2013.10.005

Source DB:  PubMed          Journal:  Cancer Genet


  5 in total

1.  NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism.

Authors:  Christopher A French; Shaila Rahman; Erica M Walsh; Simone Kühnle; Adlai R Grayson; Madeleine E Lemieux; Noam Grunfeld; Brian P Rubin; Cristina R Antonescu; Songlin Zhang; Rajkumar Venkatramani; Paola Dal Cin; Peter M Howley
Journal:  Cancer Discov       Date:  2014-05-29       Impact factor: 39.397

2.  A Biphasic Pleural Tumor with Features of an Epithelioid and Small Cell Mesothelioma: Morphologic and Molecular Findings.

Authors:  Sarah Hackman; Richard D Hammer; Lester Layfield
Journal:  Case Rep Pathol       Date:  2016-06-15

3.  A genomic case study of desmoplastic small round cell tumor: comprehensive analysis reveals insights into potential therapeutic targets and development of a monitoring tool for a rare and aggressive disease.

Authors:  Elisa Napolitano Ferreira; Bruna Durães Figueiredo Barros; Jorge Estefano de Souza; Renan Valieris Almeida; Giovana Tardin Torrezan; Sheila Garcia; Ana Cristina Victorino Krepischi; Celso Abdon Lopes de Mello; Isabela Werneck da Cunha; Clóvis Antonio Lopes Pinto; Fernando Augusto Soares; Emmanuel Dias-Neto; Ademar Lopes; Sandro José de Souza; Dirce Maria Carraro
Journal:  Hum Genomics       Date:  2016-11-18       Impact factor: 4.639

4.  Novel patient-derived models of desmoplastic small round cell tumor confirm a targetable dependency on ERBB signaling.

Authors:  Roger S Smith; Igor Odintsov; Zebing Liu; Allan Jo-Weng Lui; Takuo Hayashi; Morana Vojnic; Yoshiyuki Suehara; Lukas Delasos; Marissa S Mattar; Julija Hmeljak; Hillary A Ramirez; Melissa Shaw; Gabrielle Bui; Alifiani B Hartono; Eric Gladstone; Siddharth Kunte; Heather Magnan; Inna Khodos; Elisa De Stanchina; Michael P La Quaglia; Jinjuan Yao; Marick Laé; Sean B Lee; Lee Spraggon; Christine A Pratilas; Marc Ladanyi; Romel Somwar
Journal:  Dis Model Mech       Date:  2022-01-27       Impact factor: 5.758

5.  A Rare Case of Metastatic Desmoplastic Small Round Cell Tumour: Diagnosis and Management.

Authors:  Shahzaib Nabi; Abhijit Saste; Rohit Gulati
Journal:  Case Rep Oncol Med       Date:  2015-08-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.